Category list : Anti-obesity agents
Sort by: Newest first Oldest first A-Z Z-A
-
Clinical Pharmacist's monthly news round-up: the top 10 in the past month Subscription
What has been happening in the world of pharmacy? Here’s our pick of must-read news from the past month.
-
EMA recommends approval of liraglutide as weight loss drug Subscription
The European Medicines Agency is recommending that the prescription-only injectable drug liraglutide (Saxenda) should be granted a marketing authorisation as a weight loss product.
-
Can a lemon ever taste sweet?
Pam Mason explains why the flavour of what you have just eaten can change the flavour of what you eat next.
-
Is bariatric surgery the right approach to obesity? Subscription
Up to a million more people could be offered weight loss surgery on the NHS after NICE lowered the threshold for which patients are eligible for bariatric surgery. David Haslam, GP and chairman of the National Obesity Forum UK, and David Katz, director, Yale University Prevention Research Center, discuss the merits of the decision, and the use of ...
-
Drug for ADHD shows promise for treating binge eating disorder Subscription
A drug approved for the treatment of attention deficit-hyperactivity disorder, lisdexamfetamine dimesylate, cuts the number of binge eating days in people with binge eating disorder, according to a study.
-
Making foods more filling could help tackle obesity
Adding a chemical that helps to cause satedness after eating to food may help to reduce the amount that individuals eat and therefore reduce weight gain.
-
Scientists develop drug that curbs weight gain without reducing food intake Subscription
Scientists have developed a drug that curbs weight gain and corrects the metabolic defects associated with obesity without reducing food intake.
-
Injectable weight loss drug liraglutide approved by FDA Subscription
The US Food and Drug Administration has approved liraglutide, an injectable drug best known as an antidiabetes agent, to treat obesity in combination with lifestyle changes such as a reduced-calorie diet and exercise.
-
Researchers pinpoint new approach to treating obesity Subscription
Researchers have identified group 2 innate lymphoid cells for the first time in human white adipose tissue and shown that it limits obesity.
-
FDA adds another weight loss drug to the US market Subscription
Combination therapy Contrave is the third weight loss drug to be approved by the US FDA in recent years.
Show 10 per page20 per page50 per page
